Clinical Trial Update: ACTHAR Therapy for Central Nervous System Sarcoidosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial of ACTHAR Therapy for central nervous system sarcoidosis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoidosis

Drugs mentioned

• ACTHAR Therapy

Snippet

Sponsor: The Cleveland Clinic | Conditions: Sarcoidosis | Phase 4 | Status: WITHDRAWN